Introduction {#sec1}
============

The nation's current health care system faces ongoing financial challenges as costs of care continue to rise. In response to increased federal expenditures, the Affordable Care Act authorized the Centers for Medicare and Medicaid Services (CMS) to specialize in the development and testing of innovative health care payment models \[[@bib1]\]. These new models are designed to effectively drive costs down without compromising care delivery. In January 2014, CMS partnered with the state of Maryland and implemented a unique population-based payment model called Global Budget Revenue (GBR) as an alternative approach to the Medicare Inpatient Prospective Payment System, a fee-for-service payment system that exists in other states.

Maryland's GBR model aims to reduce hospital costs, improve quality, and decrease readmissions \[[@bib2]\]. This hospital payment system moves away from a "fee-for-service" payment system to the one focused on controlling total hospital revenue per capita, with each hospital's annual revenue defined at the beginning of each fiscal year based on volume and quality indicators measured in prior years \[[@bib3], [@bib4], [@bib5], [@bib6]\]. Specifically, the annual revenue assigned to an institution is generated by utilizing a preceding base period and subsequently adjusting for inflation, infrastructure requirements, changes in population volume, performance measures, market-shifts, and changes in payer mix \[[@bib3]\]. As a function of preexisting state law and regulation, the GBR model applies equally to all payers including commercial entities \[[@bib2],[@bib5],[@bib7]\]. This framework, which proponents argue, will lead to greater efficiencies and improvements in quality while maintaining access to care.

Under the predetermined global budget, GBR rewards institutions who spend under the budget and requires those who exceed the budget to assume financial responsibility, thereby extending financial risk to hospitals \[[@bib8]\]. Other innovative payment models currently being tested by CMS across health care institutions outside the state of Maryland substantially differ from GBR. Unlike the GBR method, payments under most bundled payment systems are retrospectively bundled to reimburse providers (ie, hospitals, post--acute care providers, physicians, and practitioners) for medical services provided during an episode of care \[[@bib9],[@bib10]\]. By establishing a 30- to 90-day care episode, or risk period, these models reward quality, as hospitals financially benefit from decreasing unnecessary utilization because of readmissions and complications. However, increases in case volume under bundled payment systems lead to increases in payments for that fiscal year. Therefore, hospitals under these models assume only a quality risk while GBR assumes a quality- and a population-based risk during any given year.

Maryland has agreed with CMS to implement GBR on the following terms over a 5-year period: (1) generation of \$330 million of Medicare savings annually within 5 years; (2) limit all-payer per capita hospital growth to 3.58% annually; (3) reduce all-cause, all-site hospital readmission rates to match national rates; and (4) reduce potentially preventable complications, such as urinary tract infections and acute myocardial infarction, by 30% \[[@bib2]\]. Despite data demonstrating statewide success in achieving overall Medicare savings \[[@bib4],[@bib11]\], published studies have yet to report on its statewide impact on inpatient total hip arthroplasty (THA) procedures. This study aimed to explore statewide changes of inpatient THA under the GBR model. Specifically, we compared before and after GBR in the state of Maryland changes in 1) patient characteristics; 2) discharge dispositions and lengths of stay (LOS); 3) costs and charges of inpatient hospital stays; and 4) 30-day readmission rates for patients who underwent primary THA.

Material and methods {#sec2}
====================

Database {#sec2.1}
--------

The Maryland State Inpatient Database (SID) was utilized for this study. The SID is a large, publicly available database, distributed by the Healthcare Cost and Utilization Project (HCUP). HCUP databases such as SID are sponsored by the Agency for Healthcare Research and Quality and developed to provide the largest collection of encounter-level health care data in the United States. This database represents 100% of all inpatient stays across the state and contains patient- and inpatient-related information. Patient demographics such as ages, sex statuses, races, comorbidities, insurances, socioeconomic statuses, and insurance payers, as well as LOS, discharge dispositions, and hospital charges are included.

Patient selection {#sec2.2}
-----------------

The Maryland SID was queried for all patients who underwent a primary THA between January 2010 and December 31, 2016. Episodes of care were identified using the appropriate ICD-9 (81.51) and ICD-10-PCS codes (0SR9029, 0SR902A, 0SR902Z, 0SR9019, 0SR901A, 0SR901Z, 0SR9039, 0SR9039, 0SR903Z, 0SR9049, 0SR904A, 0SR904Z, 0SR9069, 0SR906A, 0SR906Z, 0SR90J9, 0SR90JA, 0SR90JZ). Subsequently, cases were excluded if they possessed ICD-9 or -10 codes reflecting a revision or conversion. Pre- and post-GBR periods were grouped as January 1, 2010, to December 31, 2013, and January 1, 2014, to December 31, 2016, respectively. This yielded a total of 43,251 THAs performed during both the pre-GBR (20,838 THAs) and post-GBR (22,413 THAs) periods.

Study variables {#sec2.3}
---------------

Patient characteristics included patient demographics, health status, and primary payer. Patient demographics included age, sex, and race. Health status was assessed by utilizing the age-adjusted Charlson Comorbidity Index (CCI), which is an objective measure for assessing all-cause 10-year mortality risk and often used in research \[[@bib12],[@bib13]\]. The age-adjusted CCI is an updated version of CCI that accounts for age and has been validated as a more accurate predictor of mortality \[[@bib14]\]. Patients were classified as obese and morbidly obese if they had a body mass index (BMI) greater than 30 kg/m^2^ and greater than 40 kg/m^2^, respectively. Discharge disposition was defined according to the categories described in the HCUP website \[[@bib15]\]. Routine discharge is defined as discharge to home or self-care, whereas home health care is represented as discharge to home under care of an organized home health service organization. Charges were defined as the total cost of care billed to the primary payer. Costs were defined as the estimated costs to the hospital facility for the inpatient stay. The charge and cost data available in the Maryland SID database is recorded by the state's Health Services Cost Review Commission and relayed to HCUP. Cost estimations were made with the "Cost-to-Charge Ratio" supplemental file provided by HCUP. All costs and charges were adjusted for using the January 1, 2018, consumer price index \[[@bib16]\]. Readmissions were assessed using the "readmit" variable specific the Maryland SID. This variable is defined as any hospital readmission within a 30-day period after discharge.

Statistical analyses {#sec2.4}
--------------------

Chi-square analyses were used to analyze race, primary payer, CCI, obesity, and discharge destination. Student's t-tests were performed to compare ages, LOS, costs, charges, and readmission rates between the pre- and post-GBR groups. A *P*-value of .05 was set as the threshold for significance. All analyses were conducted using SPSS (IBM Corporation; Armonk, New York) version 25.

Results {#sec3}
=======

Patient characteristics {#sec3.1}
-----------------------

There was no difference in the proportion of minority patients undergoing THA between the pre- and post-GBR periods (18.3% vs 19.4% African American, 1.2% vs 1.3% Hispanic; *P* = .056). There were minimal differences in age-adjusted CCI between the pre- and post-GBR periods ([Fig. 1](#fig1){ref-type="fig"}). There was an increased number of obese and morbidly obese patients undergoing THA during the post-GBR period (17.2% vs 20.3% obese; *P* \< .001, 6.5% vs 7.1% morbidly obese; *P* = .018) ([Table 1](#tbl1){ref-type="table"}). The number of THA patients with Medicaid insurance increased significantly during the post-GBR period (4.0% vs 6.7%; *P* \< .001).Figure 1Chart detailing difference in the health status (as measured by age-adjusted Charlson Comorbidity Index) of total hip arthroplasty recipients during the pre-- and post--Global Budget Revenue period \**P* \< .05.Table 1Patient demographics and discharge destination among total hip arthroplasty recipients during the pre-- and post--Global Budget Revenue period.N (%)Pre-GBRPost-GBR*P*-valueNumber of procedures20,83822,413\<.001Mean age (y)[a](#tbl1fna){ref-type="table-fn"}64.23 (12.26)64.47 (11.74)\<.001Female sex9561 (56.4)10,599 (55.9).409Race White12,875 (78.3)13,889 (77.2).056 African American3010 (18.3)3485 (19.4) Hispanic203 (1.2)233 (1.3) Asian113 (0.7)142 (0.8) Native20 (0.1)19 (0.1) Other230 (1.4)216 (1.2)Body mass index Morbid obesity (\>40 kg/m^2^)1105 (6.5)1354 (7.1).018 Obesity (\>30 kg/m^2^)2923 (17.2)3839 (20.3)\<.001Primary payer Medicare8262 (48.7)9357 (49.4)\<.001 Medicaid677 (4.0)1267 (6.7) Private7572 (44.7)7846 (41.4) Self-pay94 (0.6)36 (0.2) No charge35 (0.2)6 (\<0.01) Other318 (1.9)437 (2.3)[^1]

Discharge dispositions and length of stay {#sec3.2}
-----------------------------------------

During the post-GBR period, there was an increased rate of routine discharge (33.1% vs 40.9%; *P* \< .001) and lower LOS (−0.50 days; 95% CI: −0.458 to −0.533; *P* \< .001) ([Table 2](#tbl2){ref-type="table"}).Table 2Comparisons of discharge disposition, mean lengths of stay, hospital costs, and 30-d readmission rates during the pre-- and post--Global Budget Revenue period.N (%)Pre-GBRPost-GBR95% CI for mean difference*P*-valueDischarge disposition Routine5605 (33.1)7737 (40.9)N/A\<.001 Short-term hospital39 (0.2)50 (0.3) Skilled nursing facility4865 (28.7)4589 (24.2) Home health care6409 (37.8)6529 (34.5) Against medical advice6 (\<0.01)8 (\<0.01) Died20 (0.1)11 (0.1)Mean length of stay (d)[a](#tbl2fna){ref-type="table-fn"}2.96 (1.74)2.46 (1.91)0.458 to 0.533\<.001Adjusted mean hospital costs[a](#tbl2fna){ref-type="table-fn"}\$20,129.04 (\$7656.16)\$18,711.60 (\$8171.75)\$1143.76 to \$1150.32\<.001Adjusted mean total charges[a](#tbl2fna){ref-type="table-fn"}\$26,225.39 (\$10,284.34)\$24,028.89 (\$10,622.47)\$1980.10 to \$2412.90\<.00130-d readmissions471 (2.8)357 (1.9)N/A\<.001[^2][^3]

Costs and charges {#sec3.3}
-----------------

During the post-GBR period, there was a decrease in the mean inpatient hospital costs (−\$1417.44; 95% CI −\$1143.76 to −\$1150.32; *P* \< .001) and in the mean inpatient hospital charges (−\$2196.50; 95% CI: −\$1980.10 to −\$2412.90; *P* \< .001) ([Fig. 2](#fig2){ref-type="fig"}).Figure 2Chart detailing differences in mean costs and charges by year for total hip arthroplasty recipients during the pre-- and post--Global Budget Revenue period.

Readmissions {#sec3.4}
------------

When compared with pre-GBR, there were lower 30-day readmissions in the post-GBR period (−0.9%; *P* \< .001).

Discussion {#sec4}
==========

The State of Maryland implemented a unique payment model to promote patient health and quality of care while reducing health care expenditure. In 2014, Maryland's new GBR model hoped to achieve cost containment by regulating total hospital costs per capita, a measure which may influence high demand procedures such as THA. Thus, this study evaluated the changes in inpatient THA procedures before and after the application of GBR's payment incentives. Our results demonstrated an increased number of obese, morbidly obese, and Medicaid THA recipients after the GBR initiative took effect. In addition, we found an increase in the rate of home discharges during the post-GBR period. Furthermore, our analysis demonstrated lower LOS, lower inpatient costs, and lower 30-day readmission rates after the implementation of GBR.

This study had several limitations. The Maryland SID database provides information about total charges related to the inpatient stay, but the database lacks stratification of the distribution of costs. Although we cannot specify what areas of care demonstrated cost savings such as reductions in implant or medication expenditures, our analysis can determine the presence of reduced inpatient costs between the pre- and post-GBR periods. In addition, Malmmose et al. \[[@bib5]\] reported early cost shifting from regulated hospital to unregulated outpatient spaces as more procedures were performed in the outpatient setting in 2014, a trend the SID cannot account for because the database contains only inpatient admissions. However, the patients who move to an outpatient setting are usually healthier, thus making any inpatient improvements in cost and outcomes more impressive. Furthermore, the SID database is unable to account for patients once discharged, and is unable to assess reoperations, emergency department visits, and outpatient complications beyond a 30-day window. This is a concern, as some marginalized groups, such as those on Medicaid, require more resources and a capitated budget may dissuade hospitals from providing those resources \[[@bib17]\]. Despite these limitations, this study has value as it allows for assessment of GBR's impact on high-volume procedures such as THA, Medicare's largest inpatient surgical cost \[[@bib10]\]. The Maryland inpatient database utilized for our analysis provides the largest patient sample available, allowing us to attempt to characterize GBR's statewide impact as accurately as possible.

We found differences in CCI with a slight reduction of THA in patients with one and 5 comorbidities while patients with 2 and 3 comorbidities increased. Furthermore, we found a significant increase in the proportion of patients with Medicaid. The rise in patients with 2 or 3 comorbidities can be explained by a retrospective study from Torres et al. \[[@bib18]\] suggesting the Affordable Care Act helped improve access to insurance for Americans with one or more comorbidities. Their group reported an increase in insurance coverage, regardless of insurance type, of patients with CCI of one or greater of 4.3% in states not expanding Medicaid and 5.6% in states expanding Medicaid. Our results follow this trend, as more patients shifted into either the 2 or 3 CCI category. In addition, Medicaid expansion increased access to lower total joint arthroplasty, as Delanois et al. reported in a large database study of 4,282,387 total knee arthroplasty recipients between 2009 and 2015. They demonstrated a 1.9% proportional increase in Medicaid patients receiving total knee arthroplasty after Medicaid expansion, slightly lower than our 2.7% proportional increase in Medicaid patients receiving THA after GBR implementation. As Medicaid expansion and GBR implementations overlapped, they should not be viewed as mutually exclusive programs. Our results represent a possible synergistic relationship between Medicaid expansion and GBR, as the former expands insurance coverage to those who were previously uninsured while the latter incentivizes hospitals to perform more surgeries on Medicaid patients by equalizing payments through all-payor rate setting. However, Medicaid patients may require more resources, possibly dissuading hospitals from performing THA on this already marginalized population in the future \[[@bib17]\]. This concern requires continued monitoring of trends to ensure GBR does not abandon those in greatest need.

We found a significantly greater number of obese and morbidly obese patients undergoing THA during the post-GBR period. These results may be a reflection of the changing population in the United States, as multiple reports demonstrate a greater proportion of patients undergoing THA with higher BMIs \[[@bib19]\]. Although these trends may seem contrary to the GBR goal of decreasing cost, these results are supported by studies of total joint arthroplasties such as the one performed by Roche et al. \[[@bib20]\]. Their team demonstrated a decrease in cost for TKA between 2010 and 2014, irrespective of the patient's BMI. Furthermore, because GBR takes a population-based approach, a hospital may take on more upfront costs if it improves quality of life for the patient, thus leading to cost savings from decreased future procedures and readmissions. A study by Ponnusamy et al. \[[@bib21]\] emphasized the cost-effectiveness of THA across all BMI categories when compared with conservative treatments and suggested that BMI cutoffs may unfairly lead to loss of access to care for those who would benefit from THA. Ostensibly, hospitals under GBR are able to reduce cost while maintaining access to THA for obese and morbidly obese patients.

We found a significant increase in the proportion of patients discharged home and lower LOS in the post-GBR period. Delanois et al. \[[@bib8]\] demonstrated similar results in a retrospective review evaluating GBR's impact on THA within a single Maryland institution. The authors reported an increase in home discharge (72.3% vs 78.9%; *P* = .0262) and a decrease in LOS (2.97 vs 2.63 days; *P* \< .001) during the post-GBR period. The members of this group then expanded to evaluate GBR's impact on THA across 6 tertiary centers in Maryland and reported an increase in home discharge (72.3% vs 78.9%; *P* = .0262) and lower LOS after GBR (2.75% vs 2.33 days; *P* \< .001), further supporting our statewide findings \[[@bib22]\]. The increased rates of home discharge coupled with decreased LOS may be direct consequences of acute-care facility measures aimed to improve care coordination. Specifically, in the single-institution study mentioned previously, the authors believe their findings were attained through evidence-based changes designed to standardize patient management \[[@bib8]\]. This coordination included the nursing staff, physicians, physical therapists, and physician assistants and involved a preoperative arthroplasty course, enrollment in a digital patient-engagement platform during the perioperative period, and a multimodal analgesic pathway. Thus, these changes may be comparable with other institutional variations across the state aiming to improve the patient experience and also effectively utilize their designated global budget \[[@bib23]\].

Our analysis demonstrated lower inpatient costs during the post-GBR period. In their retrospective review, Delanois et al. \[[@bib8]\] analyzed how costs and readmission rates changed after the implementation of GBR. Their study reported a decrease in mean inpatient hospital costs (\$26,575 vs \$23,712) in a single Maryland institution through 2015. In their follow-up study across 6 tertiary-care centers, the authors reported that mean inpatient costs decreased by 19% between 2012 and 2015 (*P* \< .001). However, there is concern hospital and outpatient costs are being off-loaded to unregulated spaces \[[@bib5]\] and overall hospital spending may increase. This concern has been recognized by the Health Services Cost Review Commission and has prompted the commission to create the total cost of care model, an expansion of GBR to unregulated settings. In addition, our study found slightly decreased readmissions among THA patients, which may represent increased quality of care for patients undergoing these types of procedures. This modest decrease occurred over the same 3 years in which hospital revenue growth was held to 1.58% \[[@bib24]\]. Furthermore, in a report by the Center for Medicare and Medicaid Innovation, the total hospital expenditures for Medicare patients decreased by \$554 million during the first 3 years after implementation when compared with a matched control group \[[@bib25]\]. These savings did not stop hospitals from increasing profit margins, which were higher in each year after GBR implementation than any of the previous 3 years before implementation \[[@bib25]\]. Although the decrease in readmissions may be modest, it demonstrates that cost savings and growth restrictions incurred under GBR did not have a significant impact on quality. Furthermore, efforts to improve quality by adapting to global budgets did not have a significant impact of hospital profit.

Conclusions {#sec5}
===========

The GBR model has been implemented in the State of Maryland as an attempt to reduce costs and to improve quality of care. Although previous studies have reported overall cost reductions and favorable health care outcomes, there have been no studies specifically assessing the statewide effects of GBR on THA. Our study evaluated the effects of GBR in Maryland and revealed a higher percentage of THA recipients with Medicaid insurance and reduced LOS, inpatient costs, and readmissions during the post-GBR period when compared with the pre-GBR period. These preliminary results may be encouraging for patients undergoing THA under the GBR model. Owing to early success, 26 states have applied to participate in the global budget workshop. Future studies should assess if these quality and cost improvements translate to other parts of the country.
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[^1]: Values are given as the mean and standard deviation in parentheses.

[^2]: SD, standard deviation; CI, confidence interval.

[^3]: Values are given as the mean and standard deviation in parentheses.
